Re: Farmas USA
como me revienta verla a esos precios y no poder promierdar para salirme antes, demasiado riesgo para mi, basta que promierde hoy para que mañana saquen la new con el doble de carga
THLD
como me revienta verla a esos precios y no poder promierdar para salirme antes, demasiado riesgo para mi, basta que promierde hoy para que mañana saquen la new con el doble de carga
THLD
Top 20 generics companies by 2014 revenue
It calls for scientific and manufacturing skills, a superb sales operation, and fortitude. It comes with risks but also has plenty of rewards. In the U.S., the largest drug market in the world, generic drugs account for 80% of the prescriptions written. According to data from the market intelligence miners at EvaluatePharma, worldwide sales of generic drugs in 2014 were $74.2 billion, up 7% for the year. Of that, the top 20 generics producers collected $61.7 billion, 83.1% of the take
But the fact is, most of those 20 hold only a fraction of the whole. Only the top two generics companies, Teva Pharmaceuticals ($TEVA) and Novartis ($NVS), which sells generics through its Sandoz operation, hold double-digit shares, 12.2% and 11.5% respectively. Only the top 5 generics companies, which in 2014 also included Mylan ($MYL), Actavis and Sun Pharmaceutical, held a market share above 5%. To dice it another way, those top 5 had 2014 generics sales of $35.2 billion, 47.4% of the worldwide generics sales and 57% of the sales generated by the top 20. You get the picture.
http://www.fiercepharma.com/special-reports/top-20-generics-companies-2014-revenue
NVAX
-6,16 % en AH y la página del Nasdaq donde veo el volumen en mantenimiento .
Se puede ver en otro sitio?
Edito: ya esta arreglada 700 cromos
IBB, al milimetro con la bajista ...